查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2087455

家禽疫苗市場：2026-2032年全球市場預測（按疫苗類型、目標物種、給藥途徑、最終用戶和分銷管道分類）

Poultry Vaccine Market by Vaccine Type, Species, Route Of Administration, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，家禽疫苗市場規模將達到 43.7 億美元，複合年成長率為 6.26%。

主要市場統計數據
基準年 2025 28.5億美元
預計年份：2026年 30億美元
預測年份：2032年 43.7億美元
複合年成長率 (%) 6.26%

家禽疫苗市場概覽

家禽疫苗市場是全球動物健康、食品安全和抗菌藥物合理使用的重要支柱。肉雞、蛋雞和種雞疫苗有助於預防新城疫、傳染性支氣管炎、傳染性藍斑、馬立克氏症、禽流感、雞痘、球蟲和沙門氏菌病等嚴重疾病。這些疾病會降低家禽生產力、增加死亡率、擾亂貿易，並增加治療性介入的需求。

家禽疫苗產業的變革性變化

產業趨勢正從被動疾病治療轉向預防性家禽健康管理。生產者優先考慮能夠保護雛雞出生第一天、減少生產損失並維持穩定飼料轉換率的疫苗接種方案。孵化場疫苗接種、蛋內接種和團體接種等方法在大規模商業養雞場中日益重要，有助於提高疫苗接種率並降低勞動強度。

人工智慧對家禽疫苗的累積影響

人工智慧（AI）正開始影響家禽疫苗的研發、疾病監測和現場應用。 AI驅動的流行病學建模有助於識別疾病傳播模式、評估疫情風險並確定最佳疫苗接種時間。在研發領域，機器學習可以加速抗原篩檢、免疫反應建模以及針對高突變壓力疾病的病毒株選擇。

家禽疫苗引進的主要區域趨勢

由於亞太地區家禽存欄量大規模，且新城疫、傳染性支氣管炎、傳染性禽流感和禽流感等疾病反覆出現，該地區仍是家禽疫苗需求的核心。中國和印度繼續引領區域需求，而東南亞國家則透過商業性整合和國家級疾病控制項目，不斷加強生物安全和疫苗接種基礎設施建設。北美地區在科學獸醫監督、孵化場積極進行疫苗接種以及美國農業部（USDA）和加拿大食品檢驗局（CFIA）近期記錄的高致病性禽流感疫情等方面，提高了禽流感防治能力。

家禽疫苗策略的關鍵群體分析

在東協市場，隨著商業整合企業對孵化場進行現代化改造，以及各國政府加強對家禽疾病（特別是新城疫和禽流感）的監測，家禽疫苗接種計畫正在不斷擴展。海灣合作理事會（GCC）成員國注重糧食安全、國內家禽生產能力以及在高溫生產環境下透過疫苗保障生物安全。在這些環境下，家禽群的壓力反應會增加疾病管理的複雜性。歐盟強調獸醫法規、藥品安全監測、殘留物控制和疾病報告的協調統一，因此，供應商必須遵守相關法規，做好文件記錄，並進行上市後監測。

主要國家家禽疫苗需求趨勢

美國擁有世界上最完善的家禽健康生態系統之一，這得益於美國農業部（USDA）的疾病監測、強大的生產者一體化網路以及孵化場的廣泛疫苗接種。加拿大重視協調的動物健康管理和禽流感防治，墨西哥除了國內家禽消費量高外，還持續需要控制新城疫、傳染性支氣管炎、傳染性蜂窩性組織炎和球蟲。巴西的家禽業以出口為導向，依靠健全的疫苗接種和疾病預防體系來確保進入國際市場並滿足進口國的要求。

家禽疫苗行業領導者使用的實用建議

產業領導者應根據​​各市場的疾病流行情況、產品類型和監管要求調整其疫苗組合。將針對新城疫、傳染性支氣管炎、馬立克氏病、球蟲和沙門氏菌病的基礎疫苗與先進的重組疫苗和載體疫苗相結合的公司，更有可能滿足綜合性生產商的需求。

家禽疫苗調查方法

本執行摘要基於二手資料研究和專家分析，並參考了經核實的公共領域信息，包括世界動物衛生組織（WOAH）的疾病信息、聯合國糧食及農業組織（FAO）的家禽健康指南、世界衛生組織（WHO）的抗生素耐藥性資訊來源、美國農業部（USDA）和加拿大食品檢驗局（ 出版刊物 ）的最新禽類信息、歐洲主管各國法規結構的出版物。市場分析基於疾病負擔、家禽生產趨勢、監管趨勢、引進模式以及已建立的獸醫疫苗接種實踐。

結論：家禽疫苗對食品安全至關重要。

家禽疫苗預計仍將是保障動物健康、穩定蛋白質供應和永續家禽生產的關鍵。隨著疾病威脅加劇，全球貿易對疫情的敏感度日益增強，生產者需要經過科學檢驗、實際有效且有診斷、監測和生物安全保障的疫苗接種方案。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 家禽疫苗市場：依疫苗類型分類

  • 減毒活疫苗
    • 低致病性
    • 中胚層
    • 耐熱疫苗
  • 去活化疫苗
  • 結合疫苗
  • 重組疫苗
    • 載體疫苗
    • 次單位疫苗
    • DNA疫苗
  • 類毒素疫苗

第8章 家禽疫苗市場：目標類別

  • 雞
  • 鴨子
  • 火雞

第9章 家禽疫苗市場：依給藥途徑分類

  • 注射藥物
    • 肌肉內部
    • 皮下
  • 口服
  • 噴
    • 氣霧劑
    • 起霧

第10章 家禽疫苗市場：依最終用戶分類

  • 家鄉農場
  • 商業農場
    • 肉雞養殖場
    • 雞蛋農場
  • 研究機構

第11章 家禽疫苗市場：依通路分類

  • 線上管道
    • 電子商務市場
    • 製造商網站
  • 動物醫院
    • 公立醫院
    • 私立醫院
  • 獸藥
    • 連鎖藥局
    • 獨立藥房

第12章 家禽疫苗市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 家禽疫苗市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 家禽疫苗市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Biogenesis Bago SA
  • Bioproperties Pty Ltd
  • Biovet SA
  • Bioveta, as
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • China Animal Husbandry Industry Co., Ltd.
  • CZ Veterinaria SA
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA SA
  • Huvepharma EAD
  • Indian Immunologicals Ltd.
  • Indovax Private Limited
  • Jinyu Bio-Technology Co., Ltd.
  • KM Biologics Co., Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • SAN Group BIoTech Germany GmbH
  • Tianjin Ringpu Bio-Technology Co., Ltd.
  • Vaksindo Satwa Nusantara
  • Vaxxinova International BV
  • Venky's India Limited
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
  • Zydus Animal Health Limited
Product Code: MRR-0375F3EA9C41

The Poultry Vaccine Market is projected to grow by USD 4.37 billion at a CAGR of 6.26% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.85 billion
Estimated Year [2026] USD 3.00 billion
Forecast Year [2032] USD 4.37 billion
CAGR (%) 6.26%

Poultry Vaccine Market Introduction

The poultry vaccine market is a critical pillar of global animal health, food security, and antimicrobial stewardship. Vaccines for broilers, layers, and breeders help prevent high-impact diseases such as Newcastle disease, infectious bronchitis, infectious bursal disease, Marek's disease, avian influenza, fowl pox, coccidiosis, and salmonellosis. These diseases can reduce flock productivity, increase mortality, disrupt trade, and raise the need for therapeutic interventions.

Demand is being reinforced by expanding poultry meat and egg consumption, stricter biosecurity expectations, and the economic importance of uninterrupted poultry supply chains. Verified guidance from organizations such as WOAH, FAO, WHO, USDA, and national veterinary authorities confirms that vaccination, when integrated with surveillance and farm-level biosecurity, remains one of the most effective tools for controlling endemic and transboundary poultry diseases.

Transformative Shifts in the Poultry Vaccine Landscape

The landscape is shifting from reactive disease treatment toward preventive flock health management. Producers are prioritizing vaccination schedules that protect day-old chicks, reduce production losses, and support consistent feed conversion performance. Hatchery-based vaccination, in-ovo delivery, and mass administration methods are gaining relevance because they improve coverage and reduce labor intensity across large commercial operations.

Another major shift is the rise of advanced vaccine platforms, including recombinant, vector-based, immune-complex, subunit, and live-attenuated products. These technologies are improving protection against evolving pathogens and enabling more targeted disease control. At the same time, regulators and buyers are placing greater emphasis on residue reduction, antimicrobial use reduction, traceability, documented flock health outcomes, and alignment with One Health principles.

Cumulative Impact of Artificial Intelligence on Poultry Vaccines

Artificial intelligence is beginning to influence poultry vaccine development, disease surveillance, and field execution. AI-enabled epidemiological modeling can help identify disease spread patterns, evaluate outbreak risk, and support decisions on vaccination timing. In research and development, machine learning can accelerate antigen screening, immune-response modeling, and strain selection for diseases with high mutation pressure.

AI also improves farm-level vaccine performance monitoring. Computer vision, environmental sensors, production analytics, and mortality pattern analysis can help detect early health deviations after vaccination or disease exposure. However, AI does not replace regulatory validation, challenge studies, cold-chain controls, or veterinary oversight. Its greatest value lies in making vaccination programs more predictive, measurable, and responsive.

Key Regional Insights Across Poultry Vaccine Adoption

Asia-Pacific remains central to poultry vaccine demand due to large poultry populations, intensive production systems, and recurring pressure from Newcastle disease, infectious bronchitis, infectious bursal disease, and avian influenza. China and India continue to shape regional volume, while Southeast Asian countries are strengthening biosecurity and vaccination infrastructure through commercial integration and national disease-control programs. North America is characterized by science-based veterinary oversight, strong hatchery vaccination adoption, and heightened avian influenza preparedness following recent highly pathogenic avian influenza events documented by USDA and CFIA.

Latin America, led by Brazil and Mexico, benefits from export-oriented poultry production and structured disease-control programs that prioritize flock health, traceability, and continuity of trade. Europe is driven by strict animal health regulation, advanced surveillance, and EU-level disease notification systems, with vaccination strategies shaped by risk-based control, welfare expectations, and antimicrobial reduction goals. The Middle East depends on vaccine-supported poultry self-sufficiency initiatives, particularly where climate stress, water constraints, and import dependence create supply risk. Africa shows strong long-term need as vaccination against Newcastle disease remains essential for both commercial farms and backyard poultry systems, where poultry contributes to nutrition, household income, and rural resilience.

Key Group Insights for Poultry Vaccine Strategy

ASEAN markets are expanding poultry vaccination programs as commercial integrators modernize hatcheries and governments strengthen avian disease surveillance, particularly for Newcastle disease and avian influenza. The GCC is focused on food security, domestic poultry capacity, and vaccine-supported biosecurity in high-temperature production environments where flock stress can increase disease-management complexity. The European Union emphasizes harmonized veterinary regulation, pharmacovigilance, residue control, and disease reporting, making compliance, documentation, and post-authorization monitoring essential for suppliers.

BRICS countries represent a large share of global poultry production and are influential in volume demand, local manufacturing capability, and disease-control policy, with China, India, Brazil, Russia, and South Africa each facing distinct poultry health priorities. G7 markets are distinguished by advanced veterinary infrastructure, innovation funding, diagnostic capacity, and strong regulatory scrutiny. NATO countries overlap with several advanced animal health markets where resilience of food supply chains, outbreak readiness, and cross-border disease intelligence increasingly inform poultry vaccine procurement and biosecurity planning.

Key Country Insights in Poultry Vaccine Demand

The United States has one of the most developed poultry health ecosystems, supported by USDA disease surveillance, strong integrator networks, and widespread hatchery vaccination. Canada emphasizes coordinated animal health management and avian influenza preparedness, while Mexico combines large domestic poultry consumption with sustained demand for Newcastle disease, infectious bronchitis, infectious bursal disease, and coccidiosis control. Brazil's export-focused poultry industry relies on robust vaccination and disease-prevention systems to protect international market access and support compliance with importing-country requirements.

In Europe, the United Kingdom, Germany, France, Italy, and Spain apply strict veterinary controls, with demand shaped by biosecurity, antimicrobial reduction, traceability, and poultry welfare expectations. Russia has a large domestic poultry base with continued emphasis on disease self-sufficiency, local supply reliability, and vaccination against endemic poultry pathogens. In Asia-Pacific, China and India anchor high-volume demand through large broiler and layer populations, Japan and South Korea prioritize advanced biosecurity, monitoring, and high-standard veterinary oversight, and Australia maintains strict animal health controls supported by quarantine, surveillance, and monitoring systems.

Actionable Recommendations for Poultry Vaccine Leaders

Industry leaders should align vaccine portfolios with disease prevalence, production type, and regulatory requirements in each market. Companies that combine core vaccines for Newcastle disease, infectious bronchitis, Marek's disease, infectious bursal disease, coccidiosis, and salmonella with advanced recombinant or vector-based solutions will be better positioned to meet integrator needs.

Strategic priorities include strengthening cold-chain reliability, expanding hatchery-service capabilities, investing in AI-supported surveillance tools, and generating field evidence that demonstrates flock-level performance. Partnerships with veterinary authorities, universities, diagnostics providers, and poultry integrators can improve disease intelligence and accelerate product adoption. Leaders should also prepare for stricter documentation, pharmacovigilance, traceability, and sustainability expectations across export-oriented markets.

Research Methodology for Poultry Vaccine Insights

This executive summary is developed through secondary research and expert synthesis using verified public-domain sources, including WOAH disease information, FAO poultry health guidance, WHO antimicrobial resistance principles, USDA and CFIA avian influenza updates, European regulatory frameworks, and national veterinary authority publications. Market interpretation is grounded in disease burden, poultry production trends, regulatory signals, adoption patterns, and established veterinary immunization practices.

The methodology emphasizes triangulation across scientific literature, government disease surveillance, regulatory guidance, and industry practice. Insights are reviewed for relevance to commercial poultry vaccination, including broilers, layers, breeders, hatchery operations, and integrated production systems. No unsupported market-size, market-share, or forecasting claims are used; emphasis is placed on verifiable demand drivers and strategic implications.

Conclusion: Poultry Vaccines as a Food Security Imperative

Poultry vaccines will remain indispensable to animal health, protein security, and sustainable poultry production. As disease pressure intensifies and global trade becomes more sensitive to outbreaks, producers need vaccination programs that are scientifically validated, operationally practical, and supported by diagnostics, surveillance, and biosecurity.

The market's next phase will be shaped by advanced vaccine platforms, stronger regional preparedness, AI-enabled decision support, and rising expectations for antimicrobial stewardship. Suppliers that deliver reliable products, field evidence, regulatory compliance, and integrated technical support will be best positioned to address long-term needs in the global poultry vaccine market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Poultry Vaccine Market, by Vaccine Type

  • 7.1. Live Attenuated Vaccines
    • 7.1.1. Lentogenic
    • 7.1.2. Mesogenic
    • 7.1.3. Thermostable
  • 7.2. Inactivated Vaccines
  • 7.3. Conjugate Vaccines
  • 7.4. Recombinant Vaccines
    • 7.4.1. Vector-based Vaccines
    • 7.4.2. Subunit Vaccines
    • 7.4.3. DNA Vaccines
  • 7.5. Toxoid Vaccines

8. Poultry Vaccine Market, by Species

  • 8.1. Chicken
  • 8.2. Duck
  • 8.3. Turkey

9. Poultry Vaccine Market, by Route Of Administration

  • 9.1. Injectable
    • 9.1.1. Intramuscular
    • 9.1.2. Subcutaneous
  • 9.2. Oral
  • 9.3. Spray
    • 9.3.1. Aerosol
    • 9.3.2. Fogging

10. Poultry Vaccine Market, by End User

  • 10.1. Backyard Farms
  • 10.2. Commercial Farms
    • 10.2.1. Broiler Farms
    • 10.2.2. Layer Farms
  • 10.3. Research Institutes

11. Poultry Vaccine Market, by Distribution Channel

  • 11.1. Online Channels
    • 11.1.1. E Commerce Marketplaces
    • 11.1.2. Manufacturer Websites
  • 11.2. Veterinary Hospitals
    • 11.2.1. Government Hospitals
    • 11.2.2. Private Hospitals
  • 11.3. Veterinary Pharmacies
    • 11.3.1. Chain Pharmacies
    • 11.3.2. Independent Pharmacies

12. Poultry Vaccine Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Poultry Vaccine Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Poultry Vaccine Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Biogenesis Bago S.A.
  • 16.2. Bioproperties Pty Ltd
  • 16.3. Biovet S.A.
  • 16.4. Bioveta, a.s.
  • 16.5. Boehringer Ingelheim International GmbH
  • 16.6. Ceva Sante Animale S.A.
  • 16.7. China Animal Husbandry Industry Co., Ltd.
  • 16.8. CZ Veterinaria S.A.
  • 16.9. Elanco Animal Health Incorporated
  • 16.10. Hester Biosciences Limited
  • 16.11. HIPRA S.A.
  • 16.12. Huvepharma EAD
  • 16.13. Indian Immunologicals Ltd.
  • 16.14. Indovax Private Limited
  • 16.15. Jinyu Bio-Technology Co., Ltd.
  • 16.16. KM Biologics Co., Ltd.
  • 16.17. Merck & Co., Inc.
  • 16.18. Neogen Corporation
  • 16.19. Phibro Animal Health Corporation
  • 16.20. SAN Group Biotech Germany GmbH
  • 16.21. Tianjin Ringpu Bio-Technology Co., Ltd.
  • 16.22. Vaksindo Satwa Nusantara
  • 16.23. Vaxxinova International B.V.
  • 16.24. Venky's India Limited
  • 16.25. Vetoquinol S.A.
  • 16.26. Virbac S.A.
  • 16.27. Zoetis Inc.
  • 16.28. Zydus Animal Health Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL POULTRY VACCINE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL POULTRY VACCINE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL POULTRY VACCINE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL POULTRY VACCINE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL POULTRY VACCINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL POULTRY VACCINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY SPECIES, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL POULTRY VACCINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL POULTRY VACCINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LENTOGENIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LENTOGENIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LENTOGENIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MESOGENIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MESOGENIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MESOGENIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL THERMOSTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL THERMOSTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL THERMOSTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONJUGATE VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONJUGATE VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONJUGATE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VECTOR-BASED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VECTOR-BASED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VECTOR-BASED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DNA VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DNA VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DNA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TOXOID VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TOXOID VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TOXOID VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CHICKEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CHICKEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CHICKEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DUCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DUCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DUCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TURKEY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TURKEY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TURKEY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AEROSOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AEROSOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AEROSOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FOGGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FOGGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FOGGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BACKYARD FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BACKYARD FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BACKYARD FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BROILER FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BROILER FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BROILER FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LAYER FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LAYER FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LAYER FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ONLINE CHANNELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ONLINE CHANNELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ONLINE CHANNELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL E COMMERCE MARKETPLACES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL E COMMERCE MARKETPLACES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL E COMMERCE MARKETPLACES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GOVERNMENT HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GOVERNMENT HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GOVERNMENT HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CHAIN PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CHAIN PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CHAIN PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INDEPENDENT PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INDEPENDENT PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL INDEPENDENT PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL POULTRY VACCINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 212. GCC POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 215. GCC POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 216. GCC POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 217. GCC POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 218. GCC POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 220. GCC POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. GCC POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. GCC POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 224. GCC POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. GCC POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 254. G7 POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. G7 POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 257. G7 POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 258. G7 POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 259. G7 POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 260. G7 POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. G7 POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 264. G7 POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. G7 POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 266. G7 POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 268. NATO POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. NATO POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 271. NATO POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 272. NATO POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 273. NATO POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 274. NATO POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 276. NATO POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. NATO POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. NATO POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 280. NATO POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 281. NATO POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. CANADA POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 307. CANADA POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. CANADA POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 309. CANADA POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 310. CANADA POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 311. MEXICO POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 312. MEXICO POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. MEXICO POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 314. MEXICO POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 316. MEXICO POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 317. MEXICO POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 321. MEXICO POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. MEXICO POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 323. MEXICO POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 324. MEXICO POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. BRAZIL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 328. BRAZIL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 329. BRAZIL POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 330. BRAZIL POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 331. BRAZIL POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 332. BRAZIL POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 333. BRAZIL POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 334. BRAZIL POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 335. BRAZIL POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 336. BRAZIL POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 337. BRAZIL POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 338. BRAZIL POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 353. GERMANY POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. GERMANY POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. GERMANY POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 356. GERMANY POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)
  • TABLE 357. GERMANY POULTRY VACCINE MARKET SIZE, BY SPECIES, 2018-2032 (USD MILLION)
  • TABLE 358. GERMANY POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 359. GERMANY POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 360. GERMANY POULTRY VACCINE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 361. GERMANY POULTRY VACCINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 362. GERMANY POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2018-2032 (USD MILLION)
  • TABLE 363. GERMANY POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 364. GERMANY POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 365. GERMANY POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 366. GERMANY POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 367. FRANCE POULTRY VACCINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 368. FRANCE POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
  • TABLE 369. FRANCE POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2032 (USD MILLION)
  • TABLE 370. FRANCE POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2032 (USD MILLION)

TABL